Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

NCT01061216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DEVICE: Intradermal insulin delivery: BD Research Catheter Set
DEVICE: Subcutaneous insulin delivery:ACCU-CHEK Rapid-D Infusion Set

Sponsor

Becton, Dickinson and Company